Vilin Bio Med Balance Sheet Health
Financial Health criteria checks 4/6
Vilin Bio Med has a total shareholder equity of ₹229.6M and total debt of ₹73.5M, which brings its debt-to-equity ratio to 32%. Its total assets and total liabilities are ₹333.8M and ₹104.2M respectively. Vilin Bio Med's EBIT is ₹1.5M making its interest coverage ratio 0.2. It has cash and short-term investments of ₹61.5M.
Key information
32.0%
Debt to equity ratio
₹73.55m
Debt
| Interest coverage ratio | 0.2x |
| Cash | ₹61.47m |
| Equity | ₹229.64m |
| Total liabilities | ₹104.16m |
| Total assets | ₹333.80m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: VILINBIO's short term assets (₹197.6M) exceed its short term liabilities (₹103.3M).
Long Term Liabilities: VILINBIO's short term assets (₹197.6M) exceed its long term liabilities (₹825.0K).
Debt to Equity History and Analysis
Debt Level: VILINBIO's net debt to equity ratio (5.3%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if VILINBIO's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: VILINBIO's debt is well covered by operating cash flow (20.4%).
Interest Coverage: VILINBIO's interest payments on its debt are not well covered by EBIT (0.2x coverage).